UBS Group AG - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$655,426
-55.6%
206,759
-30.4%
0.00%
Q2 2023$1,476,149
+28.5%
297,012
+27.7%
0.00%
Q1 2023$1,148,604
+34.4%
232,511
+71.1%
0.00%
Q4 2022$854,685
-56.4%
135,880
-25.1%
0.00%
-100.0%
Q3 2022$1,960,000
+25.2%
181,476
+32.2%
0.00%0.0%
Q2 2022$1,565,000
-22.9%
137,269
-38.4%
0.00%0.0%
Q1 2022$2,030,000
-13.8%
222,867
+41.3%
0.00%0.0%
Q4 2021$2,354,000
-46.9%
157,741
-8.6%
0.00%0.0%
Q3 2021$4,434,000
+343.4%
172,510
+349.8%
0.00%
Q2 2021$1,000,000
-67.0%
38,349
-55.3%
0.00%
-100.0%
Q1 2021$3,028,000
+9362.5%
85,758
+6799.3%
0.00%
Q4 2020$32,000
-40.7%
1,243
-13.8%
0.00%
Q3 2020$54,000
-57.8%
1,442
-51.6%
0.00%
Q2 2020$128,000
+106.5%
2,979
-5.5%
0.00%
Q1 2020$62,000
+3.3%
3,153
+35.8%
0.00%
Q4 2019$60,000
-43.9%
2,322
-40.9%
0.00%
Q3 2019$107,000
-93.4%
3,927
-93.5%
0.00%
-100.0%
Q2 2019$1,630,000
+508.2%
60,685
+555.5%
0.00%
Q1 2019$268,000
+230.9%
9,258
+206.4%
0.00%
Q4 2018$81,0003,0220.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders